Completed research + results
Making sustained progress in understanding, treating and ultimately curing leukemia requires advances across multiple areas, including cancer cell biology, causes and risk factors, treatments, and relapse prevention. Each year recipients of the Leukemia Research Foundation’s New Investigator Award contribute to those advances through their innovative research projects. Explore below the results and impact of recently completed research.
Hussein Abbas, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (MDS)
Xufeng Chen, PhD
New York University School of Medicine
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Jo Ishizawa, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (targeted therapy)
Max Jan, MD, PhD
Massachusetts General Hospital
Grant awarded: 2022
Disease: Leukemia (CLL)
Research focus: Treatment (immunotherapy)
Terrence Wong, MD, PhD
University of Michigan
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Emanuele Azzoni, PhD
University of Milano-Bicocca
Grant awarded: 2021
Disease: Leukemia (JMML)
Research focus: Cancer cell biology (leukemia stem cells)
George Burslem, PhD
University of Pennsylvania
Grant awarded: 2021
Disease: Leukemia (AML, ALL)
Research focus: Causes/risk factors (epigenetics)
Matt Christopher, MD, PhD
Washington University, St.Louis
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Relapse prevention (maintenance therapy)
Leslie Crews, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Multiple myeloma
Research focus: Cancer cell biology (cancer stem cells)
Ernesto Diaz-Flores, PhD
University of California, San Francisco
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Cihangir Duy, MS, PhD
Fox Chase Cancer Center
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia cell biology)
Ann-Kathrin Eisfeld, MD
The Ohio State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Pietro Genovese, PhD
Dana-Farber Cancer Institute
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Md Kamrul Hasan, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Leukemia (CLL)
Research focus: Cancer cell biology (microenvironment)
Sangmoo Jeong, PhD
Johns Hopkins University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia stem cells)
Huacheng Luo, PhD
Pennsylvania State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Mithun Shah, MD, PhD
Mayo Clinic
Grant awarded: 2021
Disease: Leukemia (MDS)
Research focus: Causes/risk factors (MDS
Alexander Valvezan, PhD
Rutgers, The State University of New Jersey
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Zhiquan Wang, PhD
Mayo Clinic - Rochester, Minnesota
Grant awarded: 2021
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Causes/risk factors (epigenetics)